Managed Account Advisors’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-13,901
Closed -$456K 2768
2014
Q3
$456K Sell
13,901
-514
-4% -$15.8K ﹤0.01% 2199
2014
Q2
$438K Sell
14,415
-3,801
-21% -$118K ﹤0.01% 2180
2014
Q1
$530K Buy
18,216
+8,977
+97% +$240K ﹤0.01% 2090
2013
Q4
$241K Buy
9,239
+7,099
+332% +$182K ﹤0.01% 2180
2013
Q3
$58K Buy
2,140
+2,076
+3,244% +$55.5K ﹤0.01% 2267
2013
Q2
$2K Buy
+64
New +$1.68K ﹤0.01% 2458

Other funds holding MED

Managed Account Advisors's MED Position: Q4 2014 in Review

Managed Account Advisors sold out of Medifast (MED) in Q4 2014, closing a stake of 13,901 shares — an estimated $456K sold.

Managed Account Advisors first reported a position in MED in Q2 2013 and held it in 6 quarters. The position peaked at $530K in Q1 2014. 124 funds tracked by Wall St. Rank hold MED as of Q4 2014.

  • Managed Account Advisors reported no remaining Medifast position as of Q4 2014 after selling out during the quarter.
  • Managed Account Advisors sold 13,901 Medifast shares in Q4 2014, an estimated $456K.
  • Managed Account Advisors first reported a position in Medifast in Q2 2013 and held it in 6 quarters.
  • Managed Account Advisors's Medifast position peaked at $530K in Q1 2014.
  • 124 funds tracked by Wall St. Rank held Medifast as of Q4 2014.

Based on Managed Account Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.